INTERVENTIONAL RADIOLOGY MARKET ANALYSIS

Interventional Radiology Market Size and Trends

The global interventional radiology market is estimated to be valued at USD 26.97 Bn in 2024 and is expected to reach USD 42.34 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

Discover market dynamics shaping the industry: Request sample copy

The global interventional radiology market is witnessing positive growth trends over the past few years. There has been a steady rise in the demand for minimally invasive procedures for the treatment of various diseases. Advancements in image-guided technology and the development of novel embolic agents, catheters, and guidewires are helping interventional radiologists to treat conditions that were traditionally managed surgically. Furthermore, the rising geriatric population prone to chronic diseases and the increasing healthcare expenditure in developing nations are some of the key factors driving the demand for interventional radiology procedures worldwide.

Increasing Demand for Interventional Radiology Devices

Increasing demand for interventional radiology devices is expected to propel the growth of the global interventional radiology market over the forecast period. Interventional radiology (IR) is a way to diagnose and treat a variety of chronic disorders without major surgery, and thus, there is an increasing demand for IR devices. In December 2020, Samsung Electronics Co. Ltd., an electronics company, launched its premium diagnostic imaging solutions in ultrasound, digital radiography, and mobile computed tomography at the Radiological Society of North America (RSNA) 2020, to expand its product portfolio in the interventional radiology market.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Increasing Burden of Chronic Diseases

Increasing burden of chronic diseases, such as cancer, is expected to boost the growth of the global interventional radiology market during the forecast period. For instance, interventional radiology uses imaging techniques, such as real-time X-rays, computed tomography, ultrasound, or magnetic resonance imaging, to guide treatments right to the cancer site. According to the National Cancer Institute, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million by 2040. Thus, with the increasing prevalence of cancer, the use of IR devices is also expected to increase at a rapid pace.

Key Takeaways of Analyst:

The global interventional radiology market has strong growth potential driven by the rising geriatric population and increasing prevalence of chronic diseases like cancer, cardiovascular disease (CVD), and others. The market is expected to be dominated by North America owing to advanced healthcare infrastructure and favorable reimbursement policies for minimally invasive procedures. Asia Pacific is anticipated to be the fastest growing region with India and China likely to be at the forefront of growth due to rising healthcare expenditure and large patient pools.

High costs associated with interventional radiology devices, coupled with lengthy approval times from regulatory bodies continue to restrain the market growth to some extent. Nonetheless, market players could gain opportunities from the increasing use of robot-assisted surgery and ongoing R&D to develop advanced imaging technologies for improved clinical outcomes. Further, the demand for refurbished equipment from price-sensitive developing nations remains untapped.

Reimbursement uncertainties in some regions also pose a challenge. Nonetheless, the growing popularity of medical tourism and increasing healthcare access in emerging countries are likely to boost adoption. The market is very competitive with focus on new product launches, partnerships, and mergers and acquisitions for technology upgrades and geographic expansion. Overall, the global interventional radiology market has a bright future if major restraints around costs and regulations are addressed.

Market Challenges: Risk of High Radiation Exposure

Risk of high radiation exposure is expected to hamper the growth of the global interventional radiology market. In interventional radiology procedures, the patient is exposed to multiple sets of radiations for therapeutic purposes. Extended exposure to radio waves can have adverse side effects for the patient, depending upon the levels of radiation the patient is exposed to. Internal exposure can sometimes cause the deposition of certain elements in bones or organs.

Market Opportunities: Increasing Preference for Minimally-Invasive Procedures

Increasing preference for minimally-invasive procedures is expected to provide significant growth opportunities for players in the global interventional radiology market. For instance, the concept behind interventional radiology is to diagnose and treat patients using minimally-invasive techniques to improve health outcomes. In April 2021, Genesis MedTech, a medical device company, announced the launch of the novel laparoscopic technology, allowing physicians to conduct minimally invasive surgery instead of open surgery to reduce risk of patients and enhance recovery time.

Discover high revenue pocket segments and roadmap to it: Request sample copy

Insights, By Product: Driving Advancements in External Beam Radiation Therapy Modalities

The product segment includes MRI systems, ultrasound imaging systems, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and others. The MRI systems sub-segment is estimated to hold 35.8% of the market share in 2024 owing to its advanced capabilities. MRI provides excellent soft tissue contrast resolution without using ionizing radiation like CT or fluoroscopy. This makes MRI the preferred imaging modality for a variety of interventional procedures. MRI also has the key advantage of multidirectional imaging which allows physicians to visualize tissues and pathologies from any angle during a procedure for precise guidance. Recent innovations have further enhanced MRI's clinical value for interventional applications. Open architecture platforms now integrate advanced visualization tools that offer real-time imaging and 3D reconstruction of target anatomies. This level of anatomical detail helps interventional radiologists more accurately navigate devices and place implants or perform biopsies of small lesions that were previously difficult to target. Upgraded coils and coils arrays also provide higher resolution images, enabling interventional procedures in smaller or more complex regions of the body. As technology advances, MRI is poised to take on an even greater role across more areas of interventional radiology. Its superior tissue imaging without ionizing radiation will continue attracting clinicians as they develop new minimally invasive techniques. This expanding scope along with ongoing enhancements in capabilities explains the strong and growing demand for MRI systems in the global interventional radiology marketplace.

Insights, By Application: Expanding Applications of Radiation Therapy

The application segment includes cardiology, urology, nephrology, oncology, gastroenterology, and others. The cardiology sub-segment is estimated to hold 31.6% of the market share in 2024. This segment encompasses a wide range of minimally-invasive diagnostic and treatment procedures performed using image guidance to access the cardiovascular system. The rising worldwide prevalence of heart disease, blockages, valve problems, and other cardiac conditions has prompted greater use of these techniques. Key drivers include the increasing geriatric population base that is highly susceptible to cardiovascular problems. Age-related declines in heart health coupled with sedentary lifestyles have amplified demands for interventional cardiology approaches. These allow treating cardiac issues using small incisions rather than open-heart surgery, thus reducing risks, recovery times, and costs. Continuous technical improvements also support segment expansion. Newer guidewires, balloon catheters, and stent platforms facilitate treating complex blockages or abnormalities with higher success rates. Bioabsorbable stents and drug-eluting varieties further minimize in-stent restenosis risks. Robotic cardiac catheterization systems and MRI-guided technologies now enable interventional cardiology in more challenging patient cases or anatomical contexts than before.

Regional Insights

To learn more about this report, Request sample copy

North America remains the dominant region in the global interventional radiology market and is estimated to hold 42.6% of the market share in 2024. With a large presence of leading medical device manufacturers and advanced healthcare infrastructure, the U.S. and Canada have established themselves as centers for innovation and adoption of new technologies in this field. Rapid dissemination of knowledge between research centers and interventional radiologists has helped drive procedure volume. Additionally, favorable reimbursement policies have made interventional procedures an economically viable option for patients.

The Asia Pacific region, led by China and India, is poised to be the fastest growing market for interventional radiology. Governments in the region have acknowledged the growing cancer burden and are actively working to expand access to advanced treatment options like interventional oncology. Economic development has increased the affordability for hospitals to invest in new medical equipment. Patients also have more willingness to pay for quality care as incomes rise. International medical device companies are seizing the opportunity to introduce next-generation products, supported by regional clinical research collaborations.

Market Report Scope

Interventional Radiology Industry News

• On February 27, 2024, Koninklijke Philips N.V, a health technology company, announced the launch of the Azurion neuro biplane system, designed to streamline neurovascular procedures and help care teams make the right decisions faster, treat more patients, and achieve better outcomes. The new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility.
• In May 2021, ESAOTE launched the MyLab X9 ultrasound system to provide the highest level of image quality and data processing quality. It is based on advanced X ULTRA technology.
• In April 2021, Carestream Health, a medical imaging company, and Ziehm Imaging, manufacturer of mobile C-arms teamed up to provide Ziehm Vision RFD C-arm, a surgical imaging system to the company’s mobile and fluoroscopic product offerings for exceptional image quality and reducing exposure significantly
• In March 2021, FUJIFILM Holdings Corporation, a healthcare company, announced that it had acquired diagnostic imaging related business of Hitachi Ltd, the company that manufactures and sells information and telecom systems, power systems, social infrastructure and industrial systems, construction machinery, started operating as a FUJIFILM fully-owned subsidiary

*Definition: Interventional radiology (IR) is a medical sub-specialty of radiology using minimally-invasive image-guided procedure to diagnose & treat diseases in nearly every organ system. Examples of treatments administered by interventional radiologists include angioplasty, stenting, image-guided thermal ablation, embolization, thrombolysis, and biopsies. These minimally invasive treatments can cure or alleviate symptoms of vascular disease, cancer, stroke, uterine fibroids, and others. The concept behind interventional radiology is to diagnose and treat patients using minimally-invasive techniques to improve health outcomes. These procedures have less risk, less pain, and less recovery time in comparison to open surgery. Thus, interventional radiology is widely used to detect and treat several diseases.

Market Segmentation

•  Product Insights (Revenue, USD Bn, 2019 - 2031)
  • MRI Systems
  • Ultrasound Imaging Systems
  • CT Scanners
  • Angiography Systems
  • Fluoroscopy Systems
  • Biopsy Devices
  • Others
•  Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Cardiology
  • Urology 
  • Nephrology
  • Oncology
  • Gastroenterology
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Shimadzu Corporation
  • Koninklijke Philips N.V
  • Siemens Healthcare GmbH
  • FUJIFILM Holdings Corporation
  • F. Hoffmann-La Roche Ltd
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Natus Medical Incorporated
  • Mennen Medical
  • Medicaid Systems
  • Atlantic Health System
  • Carestream Health
  • Samsung Medison